Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease

14Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Impaired debrisoquine metabolism resulting from defects in the cytochrome P450 CYP2D6-debrisoquine hydroxylase gene has been shown to be associated with the development of Parkinson's disease (PD). We studied two polymorphisms in this gene in 207 Chinese PD patients and 227 control subjects by polymerase chain reaction and restriction analysis. The G to A substitution at position 1934 in the junction of intron 3/exon 4 was detected in one sporadic PD patient and two control subjects, all of whom were heterozygous. The single base deletion at position 2637 in exon 5 was not detected in any of the study subjects. Such rarity of CYP2D6 polymorphism indicates PD in the Chinese population is associated with some other gene defects.

Cite

CITATION STYLE

APA

Pang, C. P., Zhang, J., Woo, J., Chan, D., Law, L. K., Tong, S. F., … Kay, R. (1998). Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson’s disease. Movement Disorders, 13(3), 529–532. https://doi.org/10.1002/mds.870130324

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free